Skip to content

Clinical trials

Phase 4 Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 4 Clear all

129 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20039
20047
20058
20068
20076
20088
20097
20107
20115
20127
20134
20144
20155
20163
20173
20185
20195
20202
20211
20225
20236
20245
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87
Unknown status19
Recruiting7
Terminated6
Withdrawn4
Active, not recruiting3
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.11
Takeda6
Yonsei University6
Novartis5
Novartis Pharmaceuticals4
Seoul National University Bundang Hospital3
Korea University Anam Hospital2
Radiant Research2
Sanofi2
Seoul National University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias129
Diabetes Mellitus, Type 225
Hypertension22
Diabetes Mellitus15
Cardiovascular Diseases12
Hypercholesterolemia12
Atherosclerosis11
Coronary Artery Disease11
Hyperlipidemias8
Glucose Metabolism Disorders7

Trials

Showing 76 to 100 of 129. Each trial links to its page on Pharma Observatory.

29 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.